Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Global cancer statistics, 2012;Torre Lindsey;CA Cancer J Clin,2015
2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016
3. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
4. Targeting lung cancer stem cells: research and clinical impacts;Zakaria;Front Oncol,2017
5. Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies;Shan;PLoS One,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis;Translational Lung Cancer Research;2023-04
2. PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study;Frontiers in Oncology;2022-11-09
3. Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment;Frontiers in Oncology;2022-09-27
4. Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer;Cells;2021-10-01
5. Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study;Frontiers in Pharmacology;2021-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3